Steven S. Myers - Dec 8, 2021 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role
Director
Signature
Steven S. Myers, By: /s/ Todd C. Girolamo, Esq., Attorney-in-Fact
Stock symbol
LSTA
Transactions as of
Dec 8, 2021
Transactions value $
$30,190
Form type
4
Date filed
12/10/2021, 04:03 PM
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Purchase $30.2K +33.8K +29.88% $0.89 147K Dec 8, 2021 Direct F1, F2
holding LSTA Common Stock 8.43K Dec 8, 2021 By Steven S Myers IRA
holding LSTA Common Stock 1.95K Dec 8, 2021 By Steven S Myers Revocable Trust dated 12/1/2000
holding LSTA Common Stock 802 Dec 8, 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.